Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 17382165)

Published in Urology on March 01, 2007

Authors

Stephen D W Beck1, Richard S Foster, Richard Bihrle, John P Donohue

Author Affiliations

1: Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. stdbeck@iupui.edu

Articles by these authors

Feasibility of omitting cortical renorrhaphy during robot-assisted partial nephrectomy: a matched analysis. J Endourol (2015) 2.05

Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission? J Clin Oncol (2009) 1.82

Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients. Eur Urol (2006) 1.78

Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol (2003) 1.70

Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients. J Urol (2007) 1.53

Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection. J Urol (2013) 1.48

Differentiating reconstructive techniques in partial nephrectomy: a propensity score analysis. Can J Urol (2015) 1.42

Ventral onlay buccal mucosa urethroplasty: a 10-year experience. Int J Urol (2013) 1.40

Use of ileum as ureteral replacement in urological reconstruction. J Urol (2008) 1.22

Primitive neuroectodermal tumors in patients with testicular germ cell tumors usually resemble pediatric-type central nervous system embryonal neoplasms and lack chromosome 22 rearrangements. Mod Pathol (2010) 1.17

A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther (2011) 1.12

Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery. J Urol (2009) 1.07

Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer (2003) 1.07

Crystal structures of complexes containing domains from two viral internal ribosome entry site (IRES) RNAs bound to the 70S ribosome. Proc Natl Acad Sci U S A (2011) 1.06

Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer. J Urol (2002) 1.05

Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer (2007) 1.04

The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol (2005) 1.02

Nephroblastoma arising in a germ cell tumor of testicular origin. Am J Surg Pathol (2004) 0.97

Histology in mixed germ cell tumors. Is there a favorite pairing? J Urol (2004) 0.96

Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol (2005) 0.95

Cystic trophoblastic tumor: a nonaggressive lesion in postchemotherapy resections of patients with testicular germ cell tumors. Am J Surg Pathol (2004) 0.95

Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol (2003) 0.93

Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors? Cancer (2003) 0.93

OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy. Hum Pathol (2006) 0.93

Bilateral testicular epidermoid cysts managed by partial orchiectomy. J Urol (2002) 0.91

Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder. Mol Cancer Ther (2010) 0.91

Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol (2004) 0.90

Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis. Am J Pathol (2003) 0.90

Early catheter removal after radical retropubic prostatectomy: long-term followup. J Urol (2003) 0.89

Positron emission tomography scans in postchemotherapy seminoma patients with residual masses: a retrospective review from Indiana University Hospital. J Clin Oncol (2006) 0.89

Clonal origin of metastatic testicular teratomas. Clin Cancer Res (2006) 0.89

Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis. Clin Cancer Res (2004) 0.88

Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate. Cancer Control (2002) 0.88

Trends in Medicare Expenditures and Financial Status, 1966-2000. Health Care Financ Rev (2000) 0.88

Interphase fluorescence in situ hybridization analysis of chromosome 12p abnormalities is useful for distinguishing epidermoid cysts of the testis from pure mature teratoma. Clin Cancer Res (2006) 0.87

Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma. Cancer Res (2003) 0.86

Molecular evidence supporting the neoplastic nature of some epidermoid cysts of the testis. Arch Pathol Lab Med (2003) 0.86

Serum tumor markers in testicular cancer. Urol Oncol (2010) 0.85

Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens. Cancer (2003) 0.85

Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer. World J Urol (2006) 0.83

Molecular genetic evidence supporting the neoplastic nature of fibrous stroma in testicular teratoma. Mod Pathol (2012) 0.82

Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell. Am J Surg Pathol (2012) 0.81

Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen? J Clin Oncol (2006) 0.81

Management of the post chemotherapy subcentimeter residual mass: the case for observation. World J Urol (2009) 0.80

Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein. BJU Int (2009) 0.80

Role of urologist in testis cancer management. J Urol (2011) 0.80

"Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin. Am J Surg Pathol (2014) 0.80

Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection. J Urol (2012) 0.79

Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor. J Urol (2005) 0.79

Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors? J Urol (2005) 0.79

Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer. Urol Oncol (2005) 0.79

Nephrectomy for metastatic renal cell carcinoma: Indiana University experience. Urology (2003) 0.79

Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection. J Urol (2010) 0.79

Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma. Mod Pathol (2008) 0.78

Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma? BJU Int (2005) 0.78

Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome. Urol Clin North Am (2007) 0.77

Is retroperitoneal histology predictive of liver histology at concurrent post-chemotherapy retroperitoneal lymph node dissection and hepatic resection? J Urol (2010) 0.77

Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer. BJU Int (2009) 0.76

Editorial comment. J Urol (2010) 0.75

Editorial comment. J Urol (2009) 0.75

Three-tiered nodal classification system for bladder cancer: a new proposal. Future Oncol (2015) 0.75

The role of retroperitoneal surgery in testis cancer. Crit Rev Oncol Hematol (2002) 0.75

Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy? J Urol (2007) 0.75